Defining a prevalence level to describe the elimination of Lymphatic Filariasis (LF) transmission and designing monitoring &amp; evaluating (M&amp;E) programmes post the cessation of mass drug administration (MDA)

Defining a prevalence level to describe the elimination of Lymphatic Filariasis (LF) transmission and designing monitoring & evaluating (M&E) programmes post the cessation of mass drug administration (MDA)

Benjamin Collyer(Imperial College London), Roy M. Anderson(NIHR Imperial Biomedical Research Centre), Michael A. Irvine(University of British Columbia), T. Déirdre Hollingsworth(University of Oxford), Mark Bradley(GlaxoSmithKline (United Kingdom))

PLoS neglected tropical diseases

October 12, 2020

Cited by 24

|Unknown|1991|6k

|Nature|1979|3.2k

|Journal of Animal Ecology|1978|1.8k

|Parasitology|1982|1.7k

|Unknown|1982|1.4k